Figure 5: Bleeding after bridging with LMW heparin in treatment with oral anticoagulants. The anti-Xa activity was way beyond the therapeutic range. Out-patient monitoring was not carried out. Copyright F. Waldfahrer.
Figure 5: Bleeding after bridging with LMW heparin in treatment with oral anticoagulants. The anti-Xa activity was way beyond the therapeutic range. Out-patient monitoring was not carried out. Copyright F. Waldfahrer.